Most Peruvian Medical Cannabis Patients Knew About Consumption Methods But Had Knowledge Gaps
Among 86 Peruvian patients using medical cannabis for at least a year, 60% knew about different consumption forms and 77% recognized the importance of product quality, but significant knowledge gaps remained about risks and regulations.
Quick Facts
What This Study Found
Among 86 patients at a Lima cannabis clinic (mean age 41, 53.4% women), 60.2% knew about cannabis consumption forms and 77.3% recognized product quality importance. Primary conditions treated: chronic pain and nausea (each 23.9%), cancer and epilepsy (each 21.6%). Knowledge correlated significantly with cannabis use duration, but most patients had incomplete understanding of risks, regulations, and safety.
Key Numbers
86 patients; mean age 41; 53.4% women; mean cannabis use 3 years; 60.2% knew consumption forms; 77.3% recognized quality importance; primary conditions: chronic pain, nausea (23.9% each), cancer, epilepsy (21.6% each)
How They Did This
Cross-sectional survey using the 22-item KUC-22 questionnaire at the CANNAVITAL clinic in Lima, Peru, assessing knowledge, attitudes, and beliefs about cannabis among 86 patients with at least one year of medical cannabis use.
Why This Research Matters
As medical cannabis programs expand globally, understanding what patients know and do not know about their treatment is critical for safety. The knowledge gaps found suggest that even experienced patients need ongoing education.
The Bigger Picture
Peru represents a growing number of countries in Latin America with medical cannabis programs. Patient education challenges seen here likely exist in many newer medical cannabis markets worldwide.
What This Study Doesn't Tell Us
Single clinic in Lima. Small sample. Selection bias (clinic patients may be more knowledgeable than general users). Self-reported knowledge may not reflect actual understanding.
Questions This Raises
- ?What specific knowledge gaps put medical cannabis patients at greatest risk?
- ?Would standardized patient education improve outcomes in medical cannabis programs?
Trust & Context
- Key Stat:
- 60% knew consumption forms but significant gaps remained in risk and safety knowledge
- Evidence Grade:
- Small cross-sectional survey at a single clinic. Descriptive data useful for program design but limited generalizability.
- Study Age:
- Published in 2024.
- Original Title:
- Patients' knowledge about the uses, risks, and beliefs surrounding the regulation and safety of Cannabis sativa L. in Peru.
- Published In:
- Heliyon, 10(7), e27068 (2024)
- Authors:
- Ramírez-Méndez, José F, Wong-Salgado, Pedro, Gámez, Peter, Solis, Pedro, Moya-Salazar, Jeel
- Database ID:
- RTHC-05639
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Do medical cannabis patients understand their treatment?
Partially. Most knew about different forms of consumption and valued quality, but had gaps in understanding risks, regulations, and safety.
What conditions were being treated?
Chronic pain and nausea were most common (each 23.9%), followed by cancer and epilepsy (each 21.6%).
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05639APA
Ramírez-Méndez, José F; Wong-Salgado, Pedro; Gámez, Peter; Solis, Pedro; Moya-Salazar, Jeel. (2024). Patients' knowledge about the uses, risks, and beliefs surrounding the regulation and safety of Cannabis sativa L. in Peru.. Heliyon, 10(7), e27068. https://doi.org/10.1016/j.heliyon.2024.e27068
MLA
Ramírez-Méndez, José F, et al. "Patients' knowledge about the uses, risks, and beliefs surrounding the regulation and safety of Cannabis sativa L. in Peru.." Heliyon, 2024. https://doi.org/10.1016/j.heliyon.2024.e27068
RethinkTHC
RethinkTHC Research Database. "Patients' knowledge about the uses, risks, and beliefs surro..." RTHC-05639. Retrieved from https://rethinkthc.com/research/ramirez-mendez-2024-patients-knowledge-about-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.